Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

RIFAMPIN for Injection

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-340-31 D-0416-2015
Class II · Moderate risk

Colistimethate for Injection USP

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-193-31 D-0415-2015
Class II · Moderate risk

Atracurium Besylate Injection

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-672-10 D-0399-2015
Class II · Moderate risk

Atracurium Besylate Injection

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-659-05 D-0398-2015
Class II · Moderate risk

Phen 15 mg - Topri 92 mg SR Cap

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D1051-2015
Class II · Moderate risk

Hydrocortisone 1.6 mg/0.5 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1062-2015
Class II · Moderate risk

Nystatin 50

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1061-2015
Class II · Moderate risk

Coconut Oil Suppository

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1060-2015
Class II · Moderate risk

Cyclandelate 200 mg Caps

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1059-2015
Class II · Moderate risk

Triest 5 mg - Progest 150 mg Capsule

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1058-2015
Class II · Moderate risk

Colchicine 0.6 mg Caps

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1057-2015
Class II · Moderate risk

Lansoprazole 3 mg/mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1056-2015
Class II · Moderate risk

Thymol 2% Solution

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1055-2015
Class II · Moderate risk

Methenamine/Phenyl Salicylate Capsule

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1054-2015
Class II · Moderate risk

DNCB 0.3% Ointment

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1053-2015
Class II · Moderate risk

Ciprodex with Amphoteracin B

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1052-2015
Class II · Moderate risk

Sildenafil 10 mg/1 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1050-2015
Class II · Moderate risk

Verapamil HCl 15% Topical Cream

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1049-2015
Class II · Moderate risk

Phenylephrine 0.5% Solution

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1048-2015
Class II · Moderate risk

Hydroxyurea 100 mg/1 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1047-2015
Class II · Moderate risk

Renacidin Irrigation Solution

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1046-2015
Class II · Moderate risk

Nifedipine 0.2% - Lidocaine 2% Jelly

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1045-2015
Class II · Moderate risk

Pyridoxine 100 mg/1 mL Syrup

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1044-2015